Skip to main navigation Skip to search Skip to main content

The osteopontin transgenic mouse is a new model for Sjögren's syndrome

  • Sehba Husain-Krautter
  • , Jill M. Kramer
  • , Wentian Li
  • , Benchang Guo
  • , Thomas L. Rothstein
  • The Elmezzi Graduate School of Molecular Medicine
  • Northwell Health System
  • Department of Pediatrics

Research output: Contribution to journalArticlepeer-review

22 Scopus citations

Abstract

Osteopontin (Opn) is a cytokine involved in both physiological and pathological processes, and is elevated in many autoimmune diseases. Sjögren's syndrome (SS) is an autoimmune disease with a strong female predilection characterized by lymphocytic infiltration of exocrine glands. We hypothesized that Opn contributes to SS pathogenesis. We examined an established SS model and found increased Opn locally and systemically. Next, we examined Opn transgenic (Opn Tg) mice for evidence of SS. Opn Tg animals exhibited lymphocytic infiltration of salivary and lacrimal glands, and Opn co-localized with the infiltrates. Moreover, saliva production was reduced, and SS autoantibodies were observed in the serum of these mice. Finally, female Opn Tg mice showed more severe disease compared to males. Taken together, these data support a role for Opn in SS pathogenesis. We identify a new model of spontaneous SS that recapitulates the human disease in terms of sex predilection, histopathology, salivary deficits, and autoantibodies.

Original languageEnglish
Pages (from-to)30-42
Number of pages13
JournalClinical Immunology
Volume157
Issue number1
DOIs
StatePublished - Mar 1 2015

Keywords

  • B cell
  • Osteopontin
  • Sialadenitis
  • Sjogren's syndrome

Fingerprint

Dive into the research topics of 'The osteopontin transgenic mouse is a new model for Sjögren's syndrome'. Together they form a unique fingerprint.

Cite this